Applying the Guidelines for Primary Hyperparathyroidism: The Path Not Taken

. 2019 Sep 1;179(9):1227-1229.

doi: 10.1001/jamainternmed.2019.1738.

Kelly Wentworth¹, Dolores Shoback^{1

2

3}

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco.
² Division of Endocrinology and Metabolism, University of California, San Francisco.
³ Endocrine Research Unit, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California.

Kelly Wentworth et al. JAMA Intern Med. 2019.

. 2019 Sep 1;179(9):1227-1229.

doi: 10.1001/jamainternmed.2019.1738.

Kelly Wentworth¹, Dolores Shoback^{1

2

3}

¹ Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco.
² Division of Endocrinology and Metabolism, University of California, San Francisco.
³ Endocrine Research Unit, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California.

No abstract available

Cited by

Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.
Seib CD, Meng T, Suh I, Cisco RM, Lin DT, Morris AM, Trickey AW, Kebebew E. Seib CD, et al. Surgery. 2021 Jan;169(1):87-93. doi: 10.1016/j.surg.2020.04.066. Epub 2020 Jul 9. Surgery. 2021. PMID: 32654861 Free PMC article.